Vikram Anand, MBA, PMP, ITIL

From cancer and COVID vaccines to CAR-T therapies and GLP-1s, the pace of innovation in human health is unprecedented. But are we truly maximizing the potential of this “golden age for medicine” in terms of patient impact? Join ZS CEO Pratap Khedkar at #BioTechX Europe on Oct. 9 as he explores the critical challenges that hinder the translation of pharma innovations into real patient impact. Learn more: https://bit.ly/47W3TNT

18

1 Comment

This whitepaper uncovers critical aspects to driving intelligent automation – from finding your why to establishing a center of excellence (COE) – while presenting compelling data to help you transition from emerging or transforming to maturing. https://bit.ly/3LkY0j8 #pharmacovigilance #safetyPV

6

“Winning Buy-In for Life Sciences Manufacturing and Supply Chain Management - with Shreyas Becker of Sanofi” https://lnkd.in/gd7mscj6 Life sciences organizations are increasingly adopting AI to improve productivity, streamline operations, and enhance quality. To ensure sustained success, it is crucial to align AI initiatives with business goals and adapt traditional return on investment (ROI) metrics. These practices are key to gaining executive support and maximizing AI’s long-term value. The McKinsey Global Institute estimates AI could generate between $60 billion and $110 billion annually for the pharmaceutical and medical product industries. This value comes from AI’s ability to accelerate drug development, approval processes, and optimize marketing strategies. Additionally, life sciences firms are using AI to enhance supply chain management, addressing key challenges in areas such as procurement and inventory. On the ‘#AIinBusiness’ podcast, Shreyas Becker, Head of AI and Data Products in Manufacturing and Supply at Sanofi, discussed the importance of securing executive buy-in by aligning AI initiatives with stakeholder priorities. His conversation with Emerj Artificial Intelligence Research Senior Editor Matthew DeMello emphasizes shifting ROI metrics from focusing solely on outcomes to measuring process optimization, enabling organizations to drive sustained improvements. This article explores two critical insights from their conversation for business leaders across logistics, manufacturing and life sciences spaces: - Aligning AI initiatives with stakeholder objectives - Shifting ROI metrics from outcomes to process optimization #AI #LifeSciences #Pharma #AIAdoption #BusinessAlignment #Productivity #SupplyChain #McKinsey #Sanofi #ROI #Innovation #AIinBusiness #AIProducts #ProcessOptimization #PharmaceuticalIndustry #ExecutiveBuyIn

2

Operational Oversight in Clinical Research: Integrations and Insights Dive in to this live webinar with IQVIA as professionals Wendy Morahan, Rathipriya B., and Prashant Bomireddipalli discuss how CDAS provide powerful analytics capabilities and a robust library of standard dashboards and reports, while also enabling the flexibility of self-service reporting and the power of generative AI to question data directly. Register now: https://ow.ly/AQ7550S8Uq0

1

This whitepaper uncovers critical aspects to driving intelligent automation – from finding your why to establishing a center of excellence (COE) – while presenting compelling data to help you transition from emerging or transforming to maturing. https://bit.ly/3ztUC2z #pharmacovigilance #safetyPV

4

1 Comment

Finding your way out of a maze is tough—but navigating through the complex world of appeals and grievances doesn’t have to be. Discover how a leading Fortune 500 healthcare payer partnered with Newgen to streamline their processes, ensuring faster, more compliant, and error-free case management. Know More: https://lnkd.in/gtC97Uda #Newgen #USHealthcare #AppealsAndGrievances

15

Generative artificial intelligence (GenAI) has the potential to have a seismic impact on human healthcare – if used in a considered and careful manner. Get the latest white paper in partnership with IQVIA: https://ow.ly/NhUw50Spr7j. #GenAIHealthcare #AIinMedicine #HealthcareAI #AIWhitePaper

2

We had the privilege of helping more than 60 #MedTech companies in 2023 overcome their pain points associated with #DataIntegration, MDM, data governance, and more. Explore how #IQVIA solutions can help you navigate these complexities: https://bit.ly/3QtyCdF

18

Outdated processes are slowing down drug safety efforts. It’s time to reimagine pharmacovigilance with hyperautomation by connecting case intake, signal detection, and more into one intelligent, seamless system. Ready to accelerate digital transformation without disrupting operations? Read Anand Jha's insights: https://bit.ly/HA1-L #Pharmacovigilance #Hyperautomation #HealthcareInnovation Dr. Gauri Puri | Curt Dunseath | Swadhin Khawas | Archie Oswal | Partha Anbil

40

1 Comment

📣📣 An Expert View from Vikas Krishan , chief digital business officer at Altimetrik. Bringing a new drug to market is an arduous and complex process, taking an average of 10 to 15 years and $2.5 billion in investments, according to industry estimates. Pharmaceutical companies are increasingly turning to artificial intelligence (AI) technologies to accelerate drug discovery, streamline clinical trials, and improve overall efficiency. However, the European Union (EU AI Act )Act which came into force on August 1, poses challenges that will impact the pharma industry's adoption of these transformative technologies. The EU AI Act aims to regulate AI systems used in the European Union, requiring them to meet strict standards for transparency, accountability and human oversight see full article 📖🔎🔍: https://lnkd.in/dWEeaEym #aipharma | #eu | #pharmaindustry | #aiact

1

Explore the synergy of HCP engagement and patient centricity in pharma. Discover how this intersection improves outcomes, enhances trust, and drives personalized care. #Pharma #PatientCare #HCPEngagement https://lnkd.in/gAE6bTVg

8

Punam Shejale, SVP and Head of Process Excellence, CitiusTech, discusses the transformative potential of Generative AI in healthcare. While acknowledging the technology's capacity to revolutionize data management and predictive analytics, she emphasizes the critical need for robust AI governance to safeguard patient privacy. Read the full article to learn more: https://lnkd.in/d4VScMEe #CitiusTech #HealthcareLimitless #GenAI

165

3 Comments

Clinical Research Organizations (CROs) need efficiency and adaptability. Flex Databases CTMS offers a modern solution to streamline trial management, enhance client satisfaction, and stay competitive. Discover how our all-in-one platform can transform your operations. 👉 https://lnkd.in/dVZbmQHT #CTMS #ClinicalTrialManagement #CRO #ClinicResearchOrganization

17

GenAI is set to make profound impacts in the life sciences industry, from optimizing compliance processes to delivering personalized HCP experiences. But here’s the truth: success with GenAI isn’t automatic—it starts with laying the right groundwork. In our new blog, Ravivrat Pandey and Kamal Konidala break down:  1️⃣ Critical steps to organize content for automated creation.  2️⃣ Creating a robust compliance framework for faster MLR reviews.  3️⃣ Structuring metadata for smarter content management and tagging.  4️⃣ Building data foundations to enable real-time, personalized HCP engagement. Want to futureproof your organization for the AI-driven era? Start with the essentials. 👉 Read the full blog here: https://lnkd.in/diXPNiQ6 

27

As Indian pharmaceutical companies supplied 4 of every 10 prescriptions in the US in 2022, generating $1.3 trillion in health care savings, a new IQVIA report highlights concerns about supply chain risks and advocates for partnerships to bolster biosimilar security and overall supply chain resilience. Read more here: https://lnkd.in/ecKcTr7J #pharma #biosimilars #us #healthcare #news

6

Explore our latest insights on the Inflation Reduction Act (IRA) and its profound implications on real-world evidence. Understand how this pivotal legislation shapes healthcare data, policy decisions, and patient outcomes. Download Report: https://lnkd.in/gv-rafMf Javed Shaikh #RWE #RWD #IRA #Report #Pharma #Lifesciences

42

Enhancing Patient Engagement in Support and Assistance Programs Vaibhav Tewari, Co-Founder and CEO, Portea, engaged in a conversation with #IndiaPharmaOutlook, discusses how pharmaceutical companies are leveraging digital innovations such as SaaS platforms, AI-powered chatbots, and secure communication tools to address patient accessibility, data privacy, and engagement. Discover More: https://bit.ly/47VPykB #digitalinnovations #dataprivacy #pharmaceuticalsupport #digitalliteracy #digitaltechnologies #pharmaceuticalindustry #AItechnologies

6

Building agility in field medical teams starts by understanding where and how they should spend their effort. Sunil John of ZS and Dr. Rav Seeruthun of health-equity.ai analyzed data to quantify teams’ true productivity. Find out where engagements are driving the greatest impact: https://bit.ly/3zfqcBA #MedicalAffairs #FutureOfMedicalAffairs

47

1 Comment